查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
光化性角化病治療全球市場規模、份額和行業趨勢分析報告：按藥物類別、療法、最終用途和地區劃分的前景和預測，2022-2028 年
市場調查報告書
商品編碼
1172721

光化性角化病治療全球市場規模、份額和行業趨勢分析報告：按藥物類別、療法、最終用途和地區劃分的前景和預測，2022-2028 年

Global Actinic Keratosis Treatment Market Size, Share & Industry Trends Analysis Report By Drug Class, By Therapy, By End-use, By Regional Outlook and Forecast, 2022 - 2028
出版日期: | 出版商: KBV Research | 英文 224 Pages | 訂單完成後即時交付

價格

全球光化性角化病治療市場規模預計在預測期內以 4.4% 的複合年增長率增長，到 2028 年達到 80 億美元。

光化性角化病 (AK) 是一種皮膚癌前病變，相當常見。 了解 AK 的危險因素和病因可以幫助個人預防 AK 的發展。 了解這種疾病的風險有助於及早發現 AK，而 AK 的治愈率很高。 日曬會導致累積性皮膚損傷。 這意味著您暴露在陽光下的時間越長，即使只是很短的時間，您患 AK 的風險就越高。

這包括在陽光下戶外工作的人、頭髮稀疏的人和被曬傷的人。 室內曬黑機發出的紫外線特別危險，因為它們會增加患 AK 等皮膚癌的風險。 此外，在赤道附近，常年紫外線很強，受紫外線影響的人也會更多。 因此，居住在赤道附近的人更容易患上 AK。

COVID-19 影響分析

COVID-19 大流行的影響包括嚴重的供應鏈停滯、股市波動、企業士氣下降以及公眾動盪和對未來的焦慮加劇。 大流行對光化性角化病治療市場產生了負面影響。 由於大多數國家的全面停工和對非必要就醫的限制，診斷和治療率大幅下降。 大多數醫院還能夠與皮膚科醫生保持持續溝通，減少因光化性角化病和其他非緊急醫療問題而轉診的患者。 然而，隨著 COVID-19 限制的全面放寬，光化性角化病治療市場有望上升。

市場增長因素

增加微創臨床操作的使用

由於臭氧層消耗和長時間暴露在陽光下，光化性角化病已變得普遍。 癌症患者的數量不斷增加，對微創 (MI) 治療的需求強烈。 預計光化性角化病會變得更加普遍，並且隨著人們越來越意識到如何控制這種疾病，對治療的需求也會增加。 隨著人們越來越意識到光化性角化病的有害影響，對治療光化性角化病的需求也在增長。 此外，與光化性角化病相關的患皮膚癌的風險增加增加了診斷和治療的頻率。

政府努力擴大並使價格更實惠

接受光化性角化病治療的患者數量也受到政府減少醫療設施使用和醫療費用負擔的影響。 隨著有吸引力的回扣計劃的推出，預計未來幾年需求將會增長。 在世界各地，許多公共和私人組織都在努力增加公眾對光化性角化病治療方案的了解。 此外，光化性角化病治療持續增長，投入巨資研發療效更高、給藥方便、定價更便宜的新藥項目。

市場約束

治療覆蓋率低，缺乏合格的專家

治療光化性角化病最重要的是有效的控制和治愈方法。 研究和實驗表明，冷凍療法和光動力療法等方法是治療光化性角化病最有效的方法。 然而，合格的醫護人員嚴重短缺，擴大了越來越多的患者與可以治療他們的醫生之間的差距。 用化學換膚治療光化性角化病也需要合格的人員，例如醫生和外科醫生。

治療觀點

光化性角化病治療市場根據治療方法分為局部治療、光動力治療和手術。 光動力療法領域在 2021 年的光化性角化病治療市場中佔據了很大的收入份額。 光動力藍光療法是一種針對光損傷、癌前老年斑和其他皮膚病的非侵入性治療方法。 將光敏藥物氨基乙□丙酸塗抹在待治療的斑點上。 然後，目標細胞被指向治療區域的藍光破壞。 可以有效治療大面積。

藥物類別展望

按藥物類型劃分，光化性角化病治療市場分為核甘代謝抑製劑、非甾體抗炎藥、免疫反應調節劑、光增強劑等。 到 2021 年，NSAIDs 部分將在光化性角化病治療市場中佔據重要的收入份額。 非甾體類抗炎藥 (NSAIDs) 不可逆或可逆地乙□化 COX 同種型，阻斷下游前列腺素，並在皮膚癌等惡性腫瘤中充當化學預防劑。很可能是這樣。

結束使用 Outlook

光化性角化病治療市場根據最終用途分為醫院、私人診所、家庭護理等。 在 2021 年的光化性角化病治療市場中，家庭護理領域佔據了很大的收入份額。 外用藥物使用的增加、患者舒適度因素、非處方 (OTC) 產品的可用性以及外用產品上市數量的增加被認為有助於家庭護理領域的擴張。

區域展望

光化性角化病治療市場按地區分析，橫跨北美、歐洲、亞太地區和 LAMEA。 北美部分在 2021 年獲得了光化性角化病治療市場的最高收入份額。 光化性角化病發病率的增加、政府的激勵措施、消費者意識的提高、醫療保健基礎設施的改善以及持續的技術突破都是導致這種上升的因素。 此外，業務增長的主要驅動力之一是北美市場上重要參與者的存在。

內容

第一章市場範圍與研究方法

  • 市場定義
  • 目的
  • 市場規模
  • 細分
    • 全球光化性角化病治療市場，按藥物分類
    • 全球光化性角化病治療市場：按治療方法分類
    • 全球光化性角化病治療市場：按最終用途分類
    • 全球光化性角化病治療市場：按地區
  • 調查方法

第 2 章市場概述

  • 簡介
    • 概覽
      • 市場構成和情景
  • 影響市場的主要因素
    • 市場驅動因素
    • 市場製約因素

第 3 章光化性角化病治療的全球市場：按藥物類別分類

  • 按地區分列的全球核甘代謝抑製劑市場
  • 按地區劃分的非甾體抗炎藥全球市場
  • 按地區劃分的免疫反應調節劑全球市場
  • 按地區分列的世界光固化劑市場
  • 世界其他地區的世界市場

第 4 章全球光化性角化病治療市場：按治療分類

  • 全球外科手術市場：按地區
  • 全球外用療法市場：按地區
  • 全球光動力療法市場：按地區

第 5 章全球光動力療法市場：最終用戶

  • 全球醫院市場：按地區
  • 全球私人診所市場：按地區
  • 全球家庭護理市場：按地區
  • 世界其他地區的世界市場

第 6 章全球光化性角化病治療市場：按地區劃分的市場

  • 北美
    • 按國家/地區劃分的北美光化性角化病治療市場
      • 美國
      • 加拿大
      • 墨西哥
      • 其他北美地區
  • 歐洲
    • 歐洲光化性角化病治療市場：按國家/地區分類
      • 德國
      • 英國
      • 法國
      • 俄羅斯
      • 西班牙
      • 意大利
      • 其他歐洲
  • 亞太地區
    • 按國家/地區劃分的亞太地區光化性角化病治療市場
      • 中國
      • 日本
      • 印度
      • 韓國
      • 新加坡
      • 馬來西亞
      • 其他亞太地區
  • 拉美
    • LAMEA 光化性角化病治療市場：按國家/地區分類
      • 巴西
      • 阿根廷
      • 阿聯酋
      • 沙特阿拉伯
      • 南非
      • 尼日利亞
      • 其他拉美地區

第七章公司簡介

  • Almirall, S.A
  • LEO Pharma A/S
  • Biofrontera AG
  • Sun Pharmaceuticals Industries Ltd.
  • 3M Company
  • Bausch Health Companies, Inc.
  • Novartis AG
  • Viatris, Inc.
  • Galderma S.A

The Global Actinic Keratosis Treatment Market size is expected to reach $8 billion by 2028, rising at a market growth of 4.4% CAGR during the forecast period.

Actinic keratosis is the most frequent precancer that develops on skin that has been chronically damaged by ultraviolet rays emitted by the sun or/and indoor tanning. This disorder is also referred to as solar keratosis. If someone already has an AK, they are more likely to go on to acquire further actinic keratoses. Since AKs can turn into squamous cell carcinoma (SCC), a frequent and occasionally invasive form of the illness, this increases the risk of developing skin cancer.

Squamous cells, one of the three primary cell types in the epidermis, are flat cells close to the skin's surface that continuously shed as new ones develop. Squamous cell carcinoma (SCC) develops when aberrant squamous cell alterations result from DNA damage brought on by exposure to UV radiation or other harmful factors. SCCs can manifest as elevated developments with a central depression, open sores, scaly red patches, and rough, thickened, or wart-like skin. SCCs can develop in various additional body parts, including the genitalia.

The skin precancer actinic keratosis is quite widespread. Knowing the risk factors and the causes of AK can assist individuals to stop it from happening. It is easier for people to identify AKs early on when they are very curable if they are aware of the disease risk. Sun exposure causes cumulative skin damage. This implies that the risk of developing AKs increases the longer people stay in the sun over time, even for small durations.

This includes persons who work outside in the sunlight, those who have thinning hair or a bald head, and those with sunburns. The UV rays that indoor tanning beds emit are particularly hazardous since they increase the risk of getting AKs and other forms of skin cancer. More people are exposed to the damaging effects of the sun when they live near the equator where UV rays are high for most of the year. Therefore, those who reside in areas near the equator have a higher chance of developing AKs.

COVID-19 Impact Analysis

A significant slowdown in the supply chain, stock market volatility, deterioration in corporate morale, and rising public confusion and fear about the future are just a few of the many effects of the COVID-19 pandemic. On the actinic keratosis treatments market, the pandemic had a negative effect. Diagnose and treatment rates were significantly lower as a result of total lockdown in the majority of nations and restrictions on non-essential doctor visits. Additionally, most hospitals maintained ongoing communication with dermatologists to reduce the number of patients who visited with actinic keratosis and other non-urgent medical issues. However, the market for actinic keratosis treatments is anticipated to rise as COVID-19 limits are loosened across the board.

Market Growth Factors

The Increased Use Of Minimally Invasive Clinical Procedures

There is a high prevalence of actinic keratosis as a consequence of ozone layer degradation and prolonged sun exposure. Increasing cancer cases and a strong desire for minimally invasive (MI) therapies are growing. Actinic keratosis is projected to become more common, and there will also be a greater need for therapies as people become more aware of how to manage their illnesses. The demand for actinic keratosis treatment is rising as people become more aware of its negative effects. Additionally, the frequency of identification and treatment has increased because of the higher risk of developing skin cancer linked to actinic keratosis.

Expanding Government Initiatives To Increase Affordability

The number of patients undergoing actinic keratosis therapy has also been impacted by government initiatives to increase access to and affordability of healthcare facilities. In the coming years, the availability of alluring rebate programs is anticipated to stimulate demand development. Around the world, a number of public and private groups are attempting to increase public knowledge of actinic keratosis treatment options. Furthermore, actinic keratosis treatments are growing along with significant investments in research & development projects to produce novel medications with higher efficacy, convenient dosage, and cheaper pricing.

Market Restraining Factors

Low Treatment Penetration And A Lack Of Qualified Specialists

The most important factor for the treatment of actinic keratosis is an effective method to control and cure it. Research and experiments have shown methods like cryotherapy and photodynamic therapy to be most effective in managing actinic keratosis. But the severe lack of qualified healthcare professionals increases the gap between the growing number of patients and the doctors who can treat it. Even for the treatment of actinic keratosis by chemical peels, qualified medical personnel and surgeons are required.

Therapy Outlook

Based on therapy, the actinic keratosis treatment market is categorized into topical, photodynamic therapy, and surgery. The photodynamic segment witnessed a significant revenue share in the actinic keratosis treatment market in 2021. A non-invasive treatment for photodamage, precancerous spots, and other skin disorders is photodynamic blue light therapy. Aminolevulinic acid, a drug that reacts to light, is applied to the spot being treated. The targeted cells are then obliterated by a blue light that is then focused on the therapy area. Large regions can be effectively treated in this way.

Drug Class Outlook

On the basis of drug class, the actinic keratosis treatment market is divided into nucleoside metabolic inhibitor, NSAIDs, immune response modifiers, photoenhancers, and others. The NSAIDs segment recorded a substantial revenue share in the actinic keratosis treatment market in 2021. Non-steroidal anti-inflammatory medicines (NSAIDs) work by irreversibly or reversibly acetylating COX isoforms, blocking downstream prostaglandins, and possibly acting as chemopreventatives in the case of malignancies like skin cancer.

End-Use Outlook

Based on end-use, the actinic keratosis treatment market is segmented into hospitals, private clinics, homecare, and others. The homecare segment acquired a significant revenue share in the actinic keratosis treatment market in 2021. The increasing usage of topical treatments, patient comfort factors, the accessibility of over-the-counter (OTC) products, and the expanding number of topical product launches are all factors contributing to the expansion of the homecare segment.

Regional Outlook

On the basis of region, the actinic keratosis treatment market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment garnered the highest revenue share in the actinic keratosis treatment market in 2021. Actinic keratosis' increasing incidence, encouraging government measures, more consumer awareness, better healthcare infrastructure improvements, and continued technical breakthroughs are all credited with the rise. One of the main causes of business growth is also the existence of important players in the market in North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Almirall, S.A, LEO Pharma A/S, Biofrontera AG, Sun Pharmaceuticals Industries Ltd., 3M Company, Bausch Health Companies, Inc., Novartis AG, Viatris, Inc., and Galderma S.A.

Scope of the Study

Market Segments covered in the Report:

By Drug Class

  • Nucleoside Metabolic Inhibitor
  • NSAIDs
  • Immune Response Modifiers
  • Photoenhancers
  • Others

By Therapy

  • Surgery
  • Topical
  • Photodynamic Therapy

By End-use

  • Hospitals
  • Private Clinics
  • Homecare
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Almirall, S.A
  • LEO Pharma A/S
  • Biofrontera AG
  • Sun Pharmaceuticals Industries Ltd.
  • 3M Company
  • Bausch Health Companies, Inc.
  • Novartis AG
  • Viatris, Inc.
  • Galderma S.A.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Actinic Keratosis Treatment Market, by Drug Class
    • 1.4.2 Global Actinic Keratosis Treatment Market, by Therapy
    • 1.4.3 Global Actinic Keratosis Treatment Market, by End-use
    • 1.4.4 Global Actinic Keratosis Treatment Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Actinic Keratosis Treatment Market by Drug Class

  • 3.1 Global Nucleoside Metabolic Inhibitor Market by Region
  • 3.2 Global NSAIDs Market by Region
  • 3.3 Global Immune Response Modifiers Market by Region
  • 3.4 Global Photoenhancers Market by Region
  • 3.5 Global Others Market by Region

Chapter 4. Global Actinic Keratosis Treatment Market by Therapy

  • 4.1 Global Surgery Market by Region
  • 4.2 Global Topical Market by Region
  • 4.3 Global Photodynamic Therapy Market by Region

Chapter 5. Global Actinic Keratosis Treatment Market by End-use

  • 5.1 Global Hospitals Market by Region
  • 5.2 Global Private Clinics Market by Region
  • 5.3 Global Homecare Market by Region
  • 5.4 Global Others Market by Region

Chapter 6. Global Actinic Keratosis Treatment Market by Region

  • 6.1 North America Actinic Keratosis Treatment Market
    • 6.1.1 North America Actinic Keratosis Treatment Market by Drug Class
      • 6.1.1.1 North America Nucleoside Metabolic Inhibitor Market by Country
      • 6.1.1.2 North America NSAIDs Market by Country
      • 6.1.1.3 North America Immune Response Modifiers Market by Country
      • 6.1.1.4 North America Photoenhancers Market by Country
      • 6.1.1.5 North America Others Market by Country
    • 6.1.2 North America Actinic Keratosis Treatment Market by Therapy
      • 6.1.2.1 North America Surgery Market by Country
      • 6.1.2.2 North America Topical Market by Country
      • 6.1.2.3 North America Photodynamic Therapy Market by Country
    • 6.1.3 North America Actinic Keratosis Treatment Market by End-use
      • 6.1.3.1 North America Hospitals Market by Country
      • 6.1.3.2 North America Private Clinics Market by Country
      • 6.1.3.3 North America Homecare Market by Country
      • 6.1.3.4 North America Others Market by Country
    • 6.1.4 North America Actinic Keratosis Treatment Market by Country
      • 6.1.4.1 US Actinic Keratosis Treatment Market
        • 6.1.4.1.1 US Actinic Keratosis Treatment Market by Drug Class
        • 6.1.4.1.2 US Actinic Keratosis Treatment Market by Therapy
        • 6.1.4.1.3 US Actinic Keratosis Treatment Market by End-use
      • 6.1.4.2 Canada Actinic Keratosis Treatment Market
        • 6.1.4.2.1 Canada Actinic Keratosis Treatment Market by Drug Class
        • 6.1.4.2.2 Canada Actinic Keratosis Treatment Market by Therapy
        • 6.1.4.2.3 Canada Actinic Keratosis Treatment Market by End-use
      • 6.1.4.3 Mexico Actinic Keratosis Treatment Market
        • 6.1.4.3.1 Mexico Actinic Keratosis Treatment Market by Drug Class
        • 6.1.4.3.2 Mexico Actinic Keratosis Treatment Market by Therapy
        • 6.1.4.3.3 Mexico Actinic Keratosis Treatment Market by End-use
      • 6.1.4.4 Rest of North America Actinic Keratosis Treatment Market
        • 6.1.4.4.1 Rest of North America Actinic Keratosis Treatment Market by Drug Class
        • 6.1.4.4.2 Rest of North America Actinic Keratosis Treatment Market by Therapy
        • 6.1.4.4.3 Rest of North America Actinic Keratosis Treatment Market by End-use
  • 6.2 Europe Actinic Keratosis Treatment Market
    • 6.2.1 Europe Actinic Keratosis Treatment Market by Drug Class
      • 6.2.1.1 Europe Nucleoside Metabolic Inhibitor Market by Country
      • 6.2.1.2 Europe NSAIDs Market by Country
      • 6.2.1.3 Europe Immune Response Modifiers Market by Country
      • 6.2.1.4 Europe Photoenhancers Market by Country
      • 6.2.1.5 Europe Others Market by Country
    • 6.2.2 Europe Actinic Keratosis Treatment Market by Therapy
      • 6.2.2.1 Europe Surgery Market by Country
      • 6.2.2.2 Europe Topical Market by Country
      • 6.2.2.3 Europe Photodynamic Therapy Market by Country
    • 6.2.3 Europe Actinic Keratosis Treatment Market by End-use
      • 6.2.3.1 Europe Hospitals Market by Country
      • 6.2.3.2 Europe Private Clinics Market by Country
      • 6.2.3.3 Europe Homecare Market by Country
      • 6.2.3.4 Europe Others Market by Country
    • 6.2.4 Europe Actinic Keratosis Treatment Market by Country
      • 6.2.4.1 Germany Actinic Keratosis Treatment Market
        • 6.2.4.1.1 Germany Actinic Keratosis Treatment Market by Drug Class
        • 6.2.4.1.2 Germany Actinic Keratosis Treatment Market by Therapy
        • 6.2.4.1.3 Germany Actinic Keratosis Treatment Market by End-use
      • 6.2.4.2 UK Actinic Keratosis Treatment Market
        • 6.2.4.2.1 UK Actinic Keratosis Treatment Market by Drug Class
        • 6.2.4.2.2 UK Actinic Keratosis Treatment Market by Therapy
        • 6.2.4.2.3 UK Actinic Keratosis Treatment Market by End-use
      • 6.2.4.3 France Actinic Keratosis Treatment Market
        • 6.2.4.3.1 France Actinic Keratosis Treatment Market by Drug Class
        • 6.2.4.3.2 France Actinic Keratosis Treatment Market by Therapy
        • 6.2.4.3.3 France Actinic Keratosis Treatment Market by End-use
      • 6.2.4.4 Russia Actinic Keratosis Treatment Market
        • 6.2.4.4.1 Russia Actinic Keratosis Treatment Market by Drug Class
        • 6.2.4.4.2 Russia Actinic Keratosis Treatment Market by Therapy
        • 6.2.4.4.3 Russia Actinic Keratosis Treatment Market by End-use
      • 6.2.4.5 Spain Actinic Keratosis Treatment Market
        • 6.2.4.5.1 Spain Actinic Keratosis Treatment Market by Drug Class
        • 6.2.4.5.2 Spain Actinic Keratosis Treatment Market by Therapy
        • 6.2.4.5.3 Spain Actinic Keratosis Treatment Market by End-use
      • 6.2.4.6 Italy Actinic Keratosis Treatment Market
        • 6.2.4.6.1 Italy Actinic Keratosis Treatment Market by Drug Class
        • 6.2.4.6.2 Italy Actinic Keratosis Treatment Market by Therapy
        • 6.2.4.6.3 Italy Actinic Keratosis Treatment Market by End-use
      • 6.2.4.7 Rest of Europe Actinic Keratosis Treatment Market
        • 6.2.4.7.1 Rest of Europe Actinic Keratosis Treatment Market by Drug Class
        • 6.2.4.7.2 Rest of Europe Actinic Keratosis Treatment Market by Therapy
        • 6.2.4.7.3 Rest of Europe Actinic Keratosis Treatment Market by End-use
  • 6.3 Asia Pacific Actinic Keratosis Treatment Market
    • 6.3.1 Asia Pacific Actinic Keratosis Treatment Market by Drug Class
      • 6.3.1.1 Asia Pacific Nucleoside Metabolic Inhibitor Market by Country
      • 6.3.1.2 Asia Pacific NSAIDs Market by Country
      • 6.3.1.3 Asia Pacific Immune Response Modifiers Market by Country
      • 6.3.1.4 Asia Pacific Photoenhancers Market by Country
      • 6.3.1.5 Asia Pacific Others Market by Country
    • 6.3.2 Asia Pacific Actinic Keratosis Treatment Market by Therapy
      • 6.3.2.1 Asia Pacific Surgery Market by Country
      • 6.3.2.2 Asia Pacific Topical Market by Country
      • 6.3.2.3 Asia Pacific Photodynamic Therapy Market by Country
    • 6.3.3 Asia Pacific Actinic Keratosis Treatment Market by End-use
      • 6.3.3.1 Asia Pacific Hospitals Market by Country
      • 6.3.3.2 Asia Pacific Private Clinics Market by Country
      • 6.3.3.3 Asia Pacific Homecare Market by Country
      • 6.3.3.4 Asia Pacific Others Market by Country
    • 6.3.4 Asia Pacific Actinic Keratosis Treatment Market by Country
      • 6.3.4.1 China Actinic Keratosis Treatment Market
        • 6.3.4.1.1 China Actinic Keratosis Treatment Market by Drug Class
        • 6.3.4.1.2 China Actinic Keratosis Treatment Market by Therapy
        • 6.3.4.1.3 China Actinic Keratosis Treatment Market by End-use
      • 6.3.4.2 Japan Actinic Keratosis Treatment Market
        • 6.3.4.2.1 Japan Actinic Keratosis Treatment Market by Drug Class
        • 6.3.4.2.2 Japan Actinic Keratosis Treatment Market by Therapy
        • 6.3.4.2.3 Japan Actinic Keratosis Treatment Market by End-use
      • 6.3.4.3 India Actinic Keratosis Treatment Market
        • 6.3.4.3.1 India Actinic Keratosis Treatment Market by Drug Class
        • 6.3.4.3.2 India Actinic Keratosis Treatment Market by Therapy
        • 6.3.4.3.3 India Actinic Keratosis Treatment Market by End-use
      • 6.3.4.4 South Korea Actinic Keratosis Treatment Market
        • 6.3.4.4.1 South Korea Actinic Keratosis Treatment Market by Drug Class
        • 6.3.4.4.2 South Korea Actinic Keratosis Treatment Market by Therapy
        • 6.3.4.4.3 South Korea Actinic Keratosis Treatment Market by End-use
      • 6.3.4.5 Singapore Actinic Keratosis Treatment Market
        • 6.3.4.5.1 Singapore Actinic Keratosis Treatment Market by Drug Class
        • 6.3.4.5.2 Singapore Actinic Keratosis Treatment Market by Therapy
        • 6.3.4.5.3 Singapore Actinic Keratosis Treatment Market by End-use
      • 6.3.4.6 Malaysia Actinic Keratosis Treatment Market
        • 6.3.4.6.1 Malaysia Actinic Keratosis Treatment Market by Drug Class
        • 6.3.4.6.2 Malaysia Actinic Keratosis Treatment Market by Therapy
        • 6.3.4.6.3 Malaysia Actinic Keratosis Treatment Market by End-use
      • 6.3.4.7 Rest of Asia Pacific Actinic Keratosis Treatment Market
        • 6.3.4.7.1 Rest of Asia Pacific Actinic Keratosis Treatment Market by Drug Class
        • 6.3.4.7.2 Rest of Asia Pacific Actinic Keratosis Treatment Market by Therapy
        • 6.3.4.7.3 Rest of Asia Pacific Actinic Keratosis Treatment Market by End-use
  • 6.4 LAMEA Actinic Keratosis Treatment Market
    • 6.4.1 LAMEA Actinic Keratosis Treatment Market by Drug Class
      • 6.4.1.1 LAMEA Nucleoside Metabolic Inhibitor Market by Country
      • 6.4.1.2 LAMEA NSAIDs Market by Country
      • 6.4.1.3 LAMEA Immune Response Modifiers Market by Country
      • 6.4.1.4 LAMEA Photoenhancers Market by Country
      • 6.4.1.5 LAMEA Others Market by Country
    • 6.4.2 LAMEA Actinic Keratosis Treatment Market by Therapy
      • 6.4.2.1 LAMEA Surgery Market by Country
      • 6.4.2.2 LAMEA Topical Market by Country
      • 6.4.2.3 LAMEA Photodynamic Therapy Market by Country
    • 6.4.3 LAMEA Actinic Keratosis Treatment Market by End-use
      • 6.4.3.1 LAMEA Hospitals Market by Country
      • 6.4.3.2 LAMEA Private Clinics Market by Country
      • 6.4.3.3 LAMEA Homecare Market by Country
      • 6.4.3.4 LAMEA Others Market by Country
    • 6.4.4 LAMEA Actinic Keratosis Treatment Market by Country
      • 6.4.4.1 Brazil Actinic Keratosis Treatment Market
        • 6.4.4.1.1 Brazil Actinic Keratosis Treatment Market by Drug Class
        • 6.4.4.1.2 Brazil Actinic Keratosis Treatment Market by Therapy
        • 6.4.4.1.3 Brazil Actinic Keratosis Treatment Market by End-use
      • 6.4.4.2 Argentina Actinic Keratosis Treatment Market
        • 6.4.4.2.1 Argentina Actinic Keratosis Treatment Market by Drug Class
        • 6.4.4.2.2 Argentina Actinic Keratosis Treatment Market by Therapy
        • 6.4.4.2.3 Argentina Actinic Keratosis Treatment Market by End-use
      • 6.4.4.3 UAE Actinic Keratosis Treatment Market
        • 6.4.4.3.1 UAE Actinic Keratosis Treatment Market by Drug Class
        • 6.4.4.3.2 UAE Actinic Keratosis Treatment Market by Therapy
        • 6.4.4.3.3 UAE Actinic Keratosis Treatment Market by End-use
      • 6.4.4.4 Saudi Arabia Actinic Keratosis Treatment Market
        • 6.4.4.4.1 Saudi Arabia Actinic Keratosis Treatment Market by Drug Class
        • 6.4.4.4.2 Saudi Arabia Actinic Keratosis Treatment Market by Therapy
        • 6.4.4.4.3 Saudi Arabia Actinic Keratosis Treatment Market by End-use
      • 6.4.4.5 South Africa Actinic Keratosis Treatment Market
        • 6.4.4.5.1 South Africa Actinic Keratosis Treatment Market by Drug Class
        • 6.4.4.5.2 South Africa Actinic Keratosis Treatment Market by Therapy
        • 6.4.4.5.3 South Africa Actinic Keratosis Treatment Market by End-use
      • 6.4.4.6 Nigeria Actinic Keratosis Treatment Market
        • 6.4.4.6.1 Nigeria Actinic Keratosis Treatment Market by Drug Class
        • 6.4.4.6.2 Nigeria Actinic Keratosis Treatment Market by Therapy
        • 6.4.4.6.3 Nigeria Actinic Keratosis Treatment Market by End-use
      • 6.4.4.7 Rest of LAMEA Actinic Keratosis Treatment Market
        • 6.4.4.7.1 Rest of LAMEA Actinic Keratosis Treatment Market by Drug Class
        • 6.4.4.7.2 Rest of LAMEA Actinic Keratosis Treatment Market by Therapy
        • 6.4.4.7.3 Rest of LAMEA Actinic Keratosis Treatment Market by End-use

Chapter 7. Company Profiles

  • 7.1 Almirall, S.A
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental and Regional Analysis
    • 7.1.4 Research & Development Expenses
    • 7.1.5 Recent strategies and developments:
      • 7.1.5.1 Partnerships, Collaborations, and Agreements:
      • 7.1.5.2 Product Launches and Product Expansions:
  • 7.2 LEO Pharma A/S
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Regional Analysis
    • 7.2.4 Research & Development Expense
    • 7.2.5 Recent strategies and developments:
      • 7.2.5.1 Partnerships, Collaborations, and Agreements:
  • 7.3 Biofrontera AG
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Research & Development Expenses
  • 7.4 Sun Pharmaceuticals Industries Ltd.
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Regional Analysis
    • 7.4.4 Research & Development Expenses
  • 7.5 3M Company
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Segmental and Regional Analysis
    • 7.5.4 Research & Development Expense
    • 7.5.5 SWOT Analysis
  • 7.6 Bausch Health Companies, Inc.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expense
  • 7.7 Novartis AG
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Segmental and Regional Analysis
    • 7.7.4 Research & Development Expense
  • 7.8 Viatris, Inc.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Segmental and Regional Analysis
    • 7.8.4 Research & Development Expense
  • 7.9 Galderma S.A.
    • 7.9.1 Company Overview

LIST OF TABLES

  • TABLE 1 Global Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
  • TABLE 2 Global Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
  • TABLE 3 Global Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 4 Global Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 5 Global Nucleoside Metabolic Inhibitor Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Nucleoside Metabolic Inhibitor Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global NSAIDs Market by Region, 2018 - 2021, USD Million
  • TABLE 8 Global NSAIDs Market by Region, 2022 - 2028, USD Million
  • TABLE 9 Global Immune Response Modifiers Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Immune Response Modifiers Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Photoenhancers Market by Region, 2018 - 2021, USD Million
  • TABLE 12 Global Photoenhancers Market by Region, 2022 - 2028, USD Million
  • TABLE 13 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
  • TABLE 16 Global Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
  • TABLE 17 Global Surgery Market by Region, 2018 - 2021, USD Million
  • TABLE 18 Global Surgery Market by Region, 2022 - 2028, USD Million
  • TABLE 19 Global Topical Market by Region, 2018 - 2021, USD Million
  • TABLE 20 Global Topical Market by Region, 2022 - 2028, USD Million
  • TABLE 21 Global Photodynamic Therapy Market by Region, 2018 - 2021, USD Million
  • TABLE 22 Global Photodynamic Therapy Market by Region, 2022 - 2028, USD Million
  • TABLE 23 Global Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
  • TABLE 24 Global Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
  • TABLE 25 Global Hospitals Market by Region, 2018 - 2021, USD Million
  • TABLE 26 Global Hospitals Market by Region, 2022 - 2028, USD Million
  • TABLE 27 Global Private Clinics Market by Region, 2018 - 2021, USD Million
  • TABLE 28 Global Private Clinics Market by Region, 2022 - 2028, USD Million
  • TABLE 29 Global Homecare Market by Region, 2018 - 2021, USD Million
  • TABLE 30 Global Homecare Market by Region, 2022 - 2028, USD Million
  • TABLE 31 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 32 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 33 Global Actinic Keratosis Treatment Market by Region, 2018 - 2021, USD Million
  • TABLE 34 Global Actinic Keratosis Treatment Market by Region, 2022 - 2028, USD Million
  • TABLE 35 North America Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
  • TABLE 36 North America Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
  • TABLE 37 North America Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 38 North America Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 39 North America Nucleoside Metabolic Inhibitor Market by Country, 2018 - 2021, USD Million
  • TABLE 40 North America Nucleoside Metabolic Inhibitor Market by Country, 2022 - 2028, USD Million
  • TABLE 41 North America NSAIDs Market by Country, 2018 - 2021, USD Million
  • TABLE 42 North America NSAIDs Market by Country, 2022 - 2028, USD Million
  • TABLE 43 North America Immune Response Modifiers Market by Country, 2018 - 2021, USD Million
  • TABLE 44 North America Immune Response Modifiers Market by Country, 2022 - 2028, USD Million
  • TABLE 45 North America Photoenhancers Market by Country, 2018 - 2021, USD Million
  • TABLE 46 North America Photoenhancers Market by Country, 2022 - 2028, USD Million
  • TABLE 47 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 48 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 49 North America Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
  • TABLE 50 North America Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
  • TABLE 51 North America Surgery Market by Country, 2018 - 2021, USD Million
  • TABLE 52 North America Surgery Market by Country, 2022 - 2028, USD Million
  • TABLE 53 North America Topical Market by Country, 2018 - 2021, USD Million
  • TABLE 54 North America Topical Market by Country, 2022 - 2028, USD Million
  • TABLE 55 North America Photodynamic Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 56 North America Photodynamic Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 57 North America Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
  • TABLE 58 North America Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
  • TABLE 59 North America Hospitals Market by Country, 2018 - 2021, USD Million
  • TABLE 60 North America Hospitals Market by Country, 2022 - 2028, USD Million
  • TABLE 61 North America Private Clinics Market by Country, 2018 - 2021, USD Million
  • TABLE 62 North America Private Clinics Market by Country, 2022 - 2028, USD Million
  • TABLE 63 North America Homecare Market by Country, 2018 - 2021, USD Million
  • TABLE 64 North America Homecare Market by Country, 2022 - 2028, USD Million
  • TABLE 65 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 66 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 67 North America Actinic Keratosis Treatment Market by Country, 2018 - 2021, USD Million
  • TABLE 68 North America Actinic Keratosis Treatment Market by Country, 2022 - 2028, USD Million
  • TABLE 69 US Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
  • TABLE 70 US Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
  • TABLE 71 US Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 72 US Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 73 US Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
  • TABLE 74 US Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
  • TABLE 75 US Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
  • TABLE 76 US Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
  • TABLE 77 Canada Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
  • TABLE 78 Canada Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
  • TABLE 79 Canada Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 80 Canada Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 81 Canada Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
  • TABLE 82 Canada Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
  • TABLE 83 Canada Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
  • TABLE 84 Canada Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
  • TABLE 85 Mexico Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
  • TABLE 86 Mexico Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
  • TABLE 87 Mexico Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 88 Mexico Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 89 Mexico Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
  • TABLE 90 Mexico Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
  • TABLE 91 Mexico Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
  • TABLE 92 Mexico Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
  • TABLE 93 Rest of North America Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
  • TABLE 94 Rest of North America Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
  • TABLE 95 Rest of North America Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 96 Rest of North America Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 97 Rest of North America Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
  • TABLE 98 Rest of North America Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
  • TABLE 99 Rest of North America Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
  • TABLE 100 Rest of North America Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
  • TABLE 101 Europe Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
  • TABLE 102 Europe Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
  • TABLE 103 Europe Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 104 Europe Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 105 Europe Nucleoside Metabolic Inhibitor Market by Country, 2018 - 2021, USD Million
  • TABLE 106 Europe Nucleoside Metabolic Inhibitor Market by Country, 2022 - 2028, USD Million
  • TABLE 107 Europe NSAIDs Market by Country, 2018 - 2021, USD Million
  • TABLE 108 Europe NSAIDs Market by Country, 2022 - 2028, USD Million
  • TABLE 109 Europe Immune Response Modifiers Market by Country, 2018 - 2021, USD Million
  • TABLE 110 Europe Immune Response Modifiers Market by Country, 2022 - 2028, USD Million
  • TABLE 111 Europe Photoenhancers Market by Country, 2018 - 2021, USD Million
  • TABLE 112 Europe Photoenhancers Market by Country, 2022 - 2028, USD Million
  • TABLE 113 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 114 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 115 Europe Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
  • TABLE 116 Europe Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
  • TABLE 117 Europe Surgery Market by Country, 2018 - 2021, USD Million
  • TABLE 118 Europe Surgery Market by Country, 2022 - 2028, USD Million
  • TABLE 119 Europe Topical Market by Country, 2018 - 2021, USD Million
  • TABLE 120 Europe Topical Market by Country, 2022 - 2028, USD Million
  • TABLE 121 Europe Photodynamic Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 122 Europe Photodynamic Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 123 Europe Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
  • TABLE 124 Europe Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
  • TABLE 125 Europe Hospitals Market by Country, 2018 - 2021, USD Million
  • TABLE 126 Europe Hospitals Market by Country, 2022 - 2028, USD Million
  • TABLE 127 Europe Private Clinics Market by Country, 2018 - 2021, USD Million
  • TABLE 128 Europe Private Clinics Market by Country, 2022 - 2028, USD Million
  • TABLE 129 Europe Homecare Market by Country, 2018 - 2021, USD Million
  • TABLE 130 Europe Homecare Market by Country, 2022 - 2028, USD Million
  • TABLE 131 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 132 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 133 Europe Actinic Keratosis Treatment Market by Country, 2018 - 2021, USD Million
  • TABLE 134 Europe Actinic Keratosis Treatment Market by Country, 2022 - 2028, USD Million
  • TABLE 135 Germany Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
  • TABLE 136 Germany Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
  • TABLE 137 Germany Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 138 Germany Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 139 Germany Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
  • TABLE 140 Germany Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
  • TABLE 141 Germany Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
  • TABLE 142 Germany Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
  • TABLE 143 UK Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
  • TABLE 144 UK Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
  • TABLE 145 UK Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 146 UK Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 147 UK Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
  • TABLE 148 UK Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
  • TABLE 149 UK Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
  • TABLE 150 UK Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
  • TABLE 151 France Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
  • TABLE 152 France Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
  • TABLE 153 France Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 154 France Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 155 France Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
  • TABLE 156 France Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
  • TABLE 157 France Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
  • TABLE 158 France Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
  • TABLE 159 Russia Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
  • TABLE 160 Russia Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
  • TABLE 161 Russia Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 162 Russia Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 163 Russia Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
  • TABLE 164 Russia Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
  • TABLE 165 Russia Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
  • TABLE 166 Russia Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
  • TABLE 167 Spain Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
  • TABLE 168 Spain Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
  • TABLE 169 Spain Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 170 Spain Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 171 Spain Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
  • TABLE 172 Spain Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
  • TABLE 173 Spain Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
  • TABLE 174 Spain Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
  • TABLE 175 Italy Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
  • TABLE 176 Italy Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
  • TABLE 177 Italy Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 178 Italy Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 179 Italy Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
  • TABLE 180 Italy Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
  • TABLE 181 Italy Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
  • TABLE 182 Italy Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
  • TABLE 183 Rest of Europe Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
  • TABLE 184 Rest of Europe Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
  • TABLE 185 Rest of Europe Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 186 Rest of Europe Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 187 Rest of Europe Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
  • TABLE 188 Rest of Europe Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
  • TABLE 189 Rest of Europe Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
  • TABLE 190 Rest of Europe Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
  • TABLE 191 Asia Pacific Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
  • TABLE 192 Asia Pacific Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
  • TABLE 193 Asia Pacific Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 194 Asia Pacific Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 195 Asia Pacific Nucleoside Metabolic Inhibitor Market by Country, 2018 - 2021, USD Million
  • TABLE 196 Asia Pacific Nucleoside Metabolic Inhibitor Market by Country, 2022 - 2028, USD Million
  • TABLE 197 Asia Pacific NSAIDs Market by Country, 2018 - 2021, USD Million
  • TABLE 198 Asia Pacific NSAIDs Market by Country, 2022 - 2028, USD Million
  • TABLE 199 Asia Pacific Immune Response Modifiers Market by Country, 2018 - 2021, USD Million
  • TABLE 200 Asia Pacific Immune Response Modifiers Market by Country, 2022 - 2028, USD Million
  • TABLE 201 Asia Pacific Photoenhancers Market by Country, 2018 - 2021, USD Million
  • TABLE 202 Asia Pacific Photoenhancers Market by Country, 2022 - 2028, USD Million
  • TABLE 203 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 204 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 205 Asia Pacific Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
  • TABLE 206 Asia Pacific Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
  • TABLE 207 Asia Pacific Surgery Market by Country, 2018 - 2021, USD Million
  • TABLE 208 Asia Pacific Surgery Market by Country, 2022 - 2028, USD Million
  • TABLE 209 Asia Pacific Topical Market by Country, 2018 - 2021, USD Million
  • TABLE 210 Asia Pacific Topical Market by Country, 2022 - 2028, USD Million
  • TABLE 211 Asia Pacific Photodynamic Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 212 Asia Pacific Photodynamic Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 213 Asia Pacific Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
  • TABLE 214 Asia Pacific Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
  • TABLE 215 Asia Pacific Hospitals Market by Country, 2018 - 2021, USD Million
  • TABLE 216 Asia Pacific Hospitals Market by Country, 2022 - 2028, USD Million
  • TABLE 217 Asia Pacific Private Clinics Market by Country, 2018 - 2021, USD Million
  • TABLE 218 Asia Pacific Private Clinics Market by Country, 2022 - 2028, USD Million
  • TABLE 219 Asia Pacific Homecare Market by Country, 2018 - 2021, USD Million
  • TABLE 220 Asia Pacific Homecare Market by Country, 2022 - 2028, USD Million
  • TABLE 221 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 222 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 223 Asia Pacific Actinic Keratosis Treatment Market by Country, 2018 - 2021, USD Million
  • TABLE 224 Asia Pacific Actinic Keratosis Treatment Market by Country, 2022 - 2028, USD Million
  • TABLE 225 China Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
  • TABLE 226 China Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
  • TABLE 227 China Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 228 China Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 229 China Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
  • TABLE 230 China Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
  • TABLE 231 China Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
  • TABLE 232 China Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
  • TABLE 233 Japan Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
  • TABLE 234 Japan Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
  • TABLE 235 Japan Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 236 Japan Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 237 Japan Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
  • TABLE 238 Japan Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
  • TABLE 239 Japan Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
  • TABLE 240 Japan Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
  • TABLE 241 India Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
  • TABLE 242 India Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
  • TABLE 243 India Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 244 India Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 245 India Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
  • TABLE 246 India Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
  • TABLE 247 India Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
  • TABLE 248 India Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
  • TABLE 249 South Korea Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
  • TABLE 250 South Korea Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
  • TABLE 251 South Korea Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 252 South Korea Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 253 South Korea Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
  • TABLE 254 South Korea Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
  • TABLE 255 South Korea Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
  • TABLE 256 South Korea Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
  • TABLE 257 Singapore Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
  • TABLE 258 Singapore Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
  • TABLE 259 Singapore Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 260 Singapore Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 261 Singapore Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
  • TABLE 262 Singapore Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
  • TABLE 263 Singapore Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
  • TABLE 264 Singapore Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
  • TABLE 265 Malaysia Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
  • TABLE 266 Malaysia Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
  • TABLE 267 Malaysia Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 268 Malaysia Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 269 Malaysia Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
  • TABLE 270 Malaysia Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
  • TABLE 271 Malaysia Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
  • TABLE 272 Malaysia Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
  • TABLE 273 Rest of Asia Pacific Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
  • TABLE 274 Rest of Asia Pacific Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
  • TABLE 275 Rest of Asia Pacific Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 276 Rest of Asia Pacific Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 277 Rest of Asia Pacific Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
  • TABLE 278 Rest of Asia Pacific Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
  • TABLE 279 Rest of Asia Pacific Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
  • TABLE 280 Rest of Asia Pacific Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
  • TABLE 281 LAMEA Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
  • TABLE 282 LAMEA Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
  • TABLE 283 LAMEA Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 284 LAMEA Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 285 LAMEA Nucleoside Metabolic Inhibitor Market by Country, 2018 - 2021, USD Million
  • TABLE 286 LAMEA Nucleoside Metabolic Inhibitor Market by Country, 2022 - 2028, USD Million
  • TABLE 287 LAMEA NSAIDs Market by Country, 2018 - 2021, USD Million
  • TABLE 288 LAMEA NSAIDs Market by Country, 2022 - 2028, USD Million
  • TABLE 289 LAMEA Immune Response Modifiers Market by Country, 2018 - 2021, USD Million
  • TABLE 290 LAMEA Immune Response Modifiers Market by Country, 2022 - 2028, USD Million
  • TABLE 291 LAMEA Photoenhancers Market by Country, 2018 - 2021, USD Million
  • TABLE 292 LAMEA Photoenhancers Market by Country, 2022 - 2028, USD Million
  • TABLE 293 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 294 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 295 LAMEA Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
  • TABLE 296 LAMEA Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
  • TABLE 297 LAMEA Surgery Market by Country, 2018 - 2021, USD Million
  • TABLE 298 LAMEA Surgery Market by Country, 2022 - 2028, USD Million
  • TABLE 299 LAMEA Topical Market by Country, 2018 - 2021, USD Million
  • TABLE 300 LAMEA Topical Market by Country, 2022 - 2028, USD Million
  • TABLE 301 LAMEA Photodynamic Therapy Market by Country, 2018 - 2021, USD Million
  • TABLE 302 LAMEA Photodynamic Therapy Market by Country, 2022 - 2028, USD Million
  • TABLE 303 LAMEA Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
  • TABLE 304 LAMEA Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
  • TABLE 305 LAMEA Hospitals Market by Country, 2018 - 2021, USD Million
  • TABLE 306 LAMEA Hospitals Market by Country, 2022 - 2028, USD Million
  • TABLE 307 LAMEA Private Clinics Market by Country, 2018 - 2021, USD Million
  • TABLE 308 LAMEA Private Clinics Market by Country, 2022 - 2028, USD Million
  • TABLE 309 LAMEA Homecare Market by Country, 2018 - 2021, USD Million
  • TABLE 310 LAMEA Homecare Market by Country, 2022 - 2028, USD Million
  • TABLE 311 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 312 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 313 LAMEA Actinic Keratosis Treatment Market by Country, 2018 - 2021, USD Million
  • TABLE 314 LAMEA Actinic Keratosis Treatment Market by Country, 2022 - 2028, USD Million
  • TABLE 315 Brazil Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
  • TABLE 316 Brazil Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
  • TABLE 317 Brazil Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 318 Brazil Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 319 Brazil Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
  • TABLE 320 Brazil Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
  • TABLE 321 Brazil Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
  • TABLE 322 Brazil Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
  • TABLE 323 Argentina Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
  • TABLE 324 Argentina Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
  • TABLE 325 Argentina Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 326 Argentina Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 327 Argentina Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
  • TABLE 328 Argentina Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
  • TABLE 329 Argentina Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
  • TABLE 330 Argentina Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
  • TABLE 331 UAE Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
  • TABLE 332 UAE Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
  • TABLE 333 UAE Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 334 UAE Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 335 UAE Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
  • TABLE 336 UAE Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
  • TABLE 337 UAE Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
  • TABLE 338 UAE Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
  • TABLE 339 Saudi Arabia Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
  • TABLE 340 Saudi Arabia Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
  • TABLE 341 Saudi Arabia Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 342 Saudi Arabia Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 343 Saudi Arabia Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
  • TABLE 344 Saudi Arabia Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
  • TABLE 345 Saudi Arabia Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
  • TABLE 346 Saudi Arabia Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
  • TABLE 347 South Africa Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
  • TABLE 348 South Africa Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
  • TABLE 349 South Africa Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 350 South Africa Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 351 South Africa Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
  • TABLE 352 South Africa Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
  • TABLE 353 South Africa Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
  • TABLE 354 South Africa Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
  • TABLE 355 Nigeria Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
  • TABLE 356 Nigeria Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
  • TABLE 357 Nigeria Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 358 Nigeria Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 359 Nigeria Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
  • TABLE 360 Nigeria Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
  • TABLE 361 Nigeria Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
  • TABLE 362 Nigeria Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
  • TABLE 363 Rest of LAMEA Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
  • TABLE 364 Rest of LAMEA Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
  • TABLE 365 Rest of LAMEA Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
  • TABLE 366 Rest of LAMEA Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
  • TABLE 367 Rest of LAMEA Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
  • TABLE 368 Rest of LAMEA Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
  • TABLE 369 Rest of LAMEA Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
  • TABLE 370 Rest of LAMEA Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
  • TABLE 371 Key Information - Almirall, S.A
  • TABLE 372 key information - LEO Pharma A/S
  • TABLE 373 Key Information - Biofrontera AG
  • TABLE 374 Key Information - Sun Pharmaceuticals Industries Ltd.
  • TABLE 375 Key Information - 3M Company
  • TABLE 376 key information - Bausch Health Companies, Inc.
  • TABLE 377 Key Information - Novartis AG
  • TABLE 378 key information - Viatris, Inc.
  • TABLE 379 Key Information - Galderma S.A.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Actinic Keratosis Treatment Market Share by Drug Class, 2021
  • FIG 3 Global Actinic Keratosis Treatment Market Share by Drug Class, 2028
  • FIG 4 Global Actinic Keratosis Treatment Market by Drug Class, 2018 - 2028, USD Million
  • FIG 5 Global Actinic Keratosis Treatment Market Share by Therapy, 2021
  • FIG 6 Global Actinic Keratosis Treatment Market Share by Therapy, 2028
  • FIG 7 Global Actinic Keratosis Treatment Market by Therapy, 2018 - 2028, USD Million
  • FIG 8 Global Actinic Keratosis Treatment Market Share by End-use, 2021
  • FIG 9 Global Actinic Keratosis Treatment Market Share by End-use, 2028
  • FIG 10 Global Actinic Keratosis Treatment Market by End-use, 2018 - 2028, USD Million
  • FIG 11 Global Actinic Keratosis Treatment Market Share by Region, 2021
  • FIG 12 Global Actinic Keratosis Treatment Market Share by Region, 2028
  • FIG 13 Global Actinic Keratosis Treatment Market by Region, 2018 - 2028, USD Million
  • FIG 14 Recent strategies and developments: Almirall, S.A
  • FIG 15 SWOT Analysis: 3M Company